On June 11, 2021, U.S. District Judge Valerie Caproni of the Southern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Brian Pavlick in Pavlick v. Repro Med Systems, Inc., 21-cv-2632 (S.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or the “Company”) materially misled investors by failing to disclose that..
Read More
After a vetting process that involved in-depth analysis of the Firm’s recent and current litigation actions, discussions with dozens of clients, colleagues, and judges, and interviews with Pomerantz partners, The Legal 500 ranked Pomerantz as a Tier 1 firm in recognition of its achievements as one of the top plaintiffs’ securities litigation firms in the United States. In describing their experiences with Pomerantz, testimonials from anonymous referees included: “The qualities of diligence…
Read More
On June 2, 2021, U.S. District Judge Karen Gren Scholer of the Northern District of Texas – Dallas Division appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Mohsen Javaherneshan in Javaherneshan v. MoneyGram International, Inc., 21-cv-815 (N.D. Tex.), a securities action brought on behalf of a class of defrauded investors concerning allegations that MoneyGram International, Inc. failed to disclose risks…
Read More
Chambers USA has ranked Pomerantz Managing Partner Jeremy A. Lieberman as one of the top plaintiffs’ lawyers in the nation and, for the second year running, has recognized Pomerantz as one of the top plaintiffs’ securities litigation firms in the nation and New York in 2021. Praising Pomerantz’s increasing visibility as “highly regarded force” and a “a prominent player” on the plaintiffs’ side of securities class actions…
Read More
On May 20, 2021, U.S. District Judge Michael M. Baylson of the Eastern District of Pennsylvania granted class certification to investors and appointed Pomerantz LLP as Co-Lead Class Counsel in Pelletier v. Endo International plc et al, 2:17-cv-05114 (E.D. Pa.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Endo International plc inflated its revenue from generic pharmaceuticals by misrepresenting its pricing practices.
Read More
Pomerantz is proud to announce that Of Counsel Omar Jafri and associate Daryoush Behbood have been recognized by the National Law Journal as Rising Stars of the Plaintiffs Bar in 2021. In this new category in its Elite Trial Lawyers competition, the National Law Journal honored a select group of lawyers under the age of 40 who “demonstrated repeated success in cutting-edge work on behalf of plaintiffs over the last 18 months [and] possess a solid track record of clients wins over the past three to five years.”
Read More
Pomerantz LLP is proud to announce that partner Emma Gilmore has been recognized by the National Law Journal as an Elite Woman of the Plaintiffs’ Bar in 2021 — an award given to only 11 “women lawyers who have consistently excelled in high-stakes matters on behalf of plaintiffs over the course of their careers.” Emma is one of only two women in the field of securities litigation who were so honored this year.
Read More
On April 28, 2021, U.S. District Judge J. Paul Oetken of the Southern District of New York appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiff Nuggehalli Balmukund Nandkumar in In re AstraZeneca plc Sec. Litig., 21-cv-722 (S.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that AstraZeneca plc failed to disclose to investors that its clinical trials…
Read More
On April 19, 2021, U.S. District Judge Kiyo A. Matsumoto of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiffs Yasser Abed and Evay Avbenake in Cushman v. Fortress Biotech, Inc., 20-cv-5767 (E.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Fortress Biotech, Inc. failed to disclose that IV Tramadol…
Read More
On April 8, 2021, U.S. District Judge David O. Carter of the Central District of California (Western Division) appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiffs Betty Kalmanson, Lawrence Kalmanson and Shawn Kalmanson in In re GoodRx Holdings, Inc. Securities Litigation, 2:20-cv-11444-DOC-PD (C.D.Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that GoodRx Holdings…
Read More
On March 17, 2021, U.S. Magistrate Judge Roanne L. Mann of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Lawrence Kelemen in In re Northern Dynasty Minerals Ltd. Sec. Litig., 20-cv-5917 (E.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Northern Dynasty Minerals, Inc. misled investors regarding the compliance…
Read More
On March 12, 2021, in Klein v. Altria Group, Inc. et al (3:20-cv-00075-DJNVAED), U.S. District Judge David J. Novak in the Eastern District of Virginia denied Altria Group, Inc.’s (“Altria”) and JUUL Labs, Inc’s (“JUUL”) motions to dismiss the plaintiffs’ complaint. The complaint alleges Exchange Act violations against JUUL, Altria and certain officers of each arising from Altria’s investment in JUUL and the failure to disclose their marketing of highly addictive nicotine products to kids…
Read More
Pomerantz Partner Emma Gilmore will be a featured speaker at the Practising Law Institute’s upcoming “Securities Litigation 2021: From Investigation to Trial” online program. Recognizing that the landscape of securities litigation is constantly evolving, PLI’s program will take participants through the process — “from the initial government investigation to the filing of the civil cases…
Read More
On March 11, 2021, Chief U.S. District Judge K. Michael Moore of the Southern District of Florida appointed Pomerantz LLP as Co-Lead Counsel on behalf of Lead Plaintiff Paul J. Graney in Graney v. Restaurant Brands International, Inc., 21-cv-20508 (S.D. Fla.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Restaurant Brands International misled investors…
Read More
In a hotly contested issue before the United States Supreme Court affecting investors’ rights to recoup damages from publicly traded companies as a result of securities fraud, Pomerantz LLP submitted the sole amicus brief on behalf of twenty-seven of the foremost U.S. scholars in the field of evidence. One of the two issues before the High Court in Goldman Sachs…
Read More
On March 1, 2021, Pomerantz received a very favorable decision from Judge Michael M. Baylson in Alberici v. Recro Pharma, Inc. et al, 2:18-cv-02279, a case currently pending in the Eastern District of Pennsylvania, when U.S. District Judge Michael M. Baylson issued a decision denying Defendants’ motion to dismiss the Second Amended Complaint. The Court issued a decision denying defendants’ motion to dismiss the Second Amended Complaint, holding that pled sufficient facts to support the reasonable inference…
Read More
On February 23, 2021, U.S. District Judge Stanley Blumenfeld, Jr. of the Central District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiff Suresh Goyal in Hershewe v. JOYY Inc. et al., 20-cv-10611 (C.D. Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that JOYY Inc. misled investors regarding the source of its streaming traffic and the amount of its streaming revenue.
Read More
On February 17, 2021, U.S. District Judge Liam O’Grady of the Eastern District of Virginia appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff James Boykin in In re K12 Inc. Securities Litigation, 20-cv-1419 (E.D. Va.), a securities action brought on behalf of a class of defrauded investors concerning allegations that K12 Inc. misled investors regarding its ability to meet the increased technological, administrative and infrastructure demands on its online…
Read More
On February 4, 2021, U.S. District Judge Edward M. Chen of the Northern District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiffs Hosam Alqurashi in Zosano Pharma Corporation, 20-cv-7625 (N.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Zosano Pharma Corporation misled investors regarding the results from…
Read More
On February 4, 2021, U.S. District Judge Michael M. Baylson of the Eastern District of Pennsylvania appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiffs Alexandre Pelletier, Nathan Joseph Dole, and Lane A. Wingard in Pelletier v. Endo International plc, 17-cv-5114 (E.D. Pa.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Endo International…
Read More
